Proteomics-based evidence for a pro-oncogenic role of ESRP1 in human colorectal cancer cells

13Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The RNA-binding protein, Epithelial Splicing Regulatory Protein 1 (ESRP1) can promote or suppress tumorigenesis depending on the cell type and disease context. In colorectal cancer, we have previously shown that aberrantly high ESRP1 expression can drive tumor progression. In order to unveil the mechanisms by which ESRP1 can modulate cancer traits, we searched for proteins affected by modulation of Esrp1 in two human colorectal cancer cell lines, HCA24 and COLO320DM, by proteomics analysis. Proteins hosted by endogenous ESRP1 ribonucleoprotein complex in HCA24 cells were also analyzed following RNA-immunoprecipitation. Proteomics data were complemented with bioinformatics approach to exploit publicly available data on protein-protein interaction (PPI). Gene Ontology was analysed to identify a common molecular signature possibly explaining the pro-tumorigenic role of ESRP1. Interestingly, proteins identified herein support a role for ESRP1 in response to external stimulus, regulation of cell cycle and hypoxia. Our data provide further insights into factors affected by and entwined with ESRP1 in colorectal cancer.

Cite

CITATION STYLE

APA

Ala, U., Manco, M., Mandili, G., Tolosano, E., Novelli, F., Provero, P., … Fagoonee, S. (2020). Proteomics-based evidence for a pro-oncogenic role of ESRP1 in human colorectal cancer cells. International Journal of Molecular Sciences, 21(2). https://doi.org/10.3390/ijms21020575

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free